Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma
Recruitment status was: Active, not recruiting
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells.
PURPOSE: Phase III trial to study the effectiveness of combination chemotherapy in treating children who have non-Hodgkin's lymphoma.
Drug: daunorubicin hydrochloride
Drug: mitoxantrone hydrochloride
Drug: vincristine sulfate
Radiation: radiation therapy
|Study Design:||Primary Purpose: Treatment|
|Official Title:||Phase III Study of Combination Chemotherapy in Children With T Cell and Pre-B Cell Non-Hodgkin's Lymphoma|
|Study Start Date:||June 1998|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00003650
|Centre Leon Berard|
|Lyon, France, 69373|
|Study Chair:||Christophe Bergeron||Centre Leon Berard|